Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Ukunqoba Izinselele Ekwelashweni Kwe-CAR-T Kwama-T-Cell Blood Cancers

2024-12-11

Ukwelashwa kwe-Chimeric Antigen Receptor T-cell (CAR-T) kuye kwabonakala kuyindlela yokwelapha eyinhloko yezifo ezibangelwa yigazi ezibangelwa yi-B-cell, okunikeza ukusebenza kahle nokuphepha okuphezulu. Kodwa-ke, ukusetshenziswa kwayo ezifweni ezibangelwa yigazi ezibangelwa yi-T-cell, njenge-T-cell acute lymphoblastic leukemia (T-ALL) kanye ne-peripheral I-T-Cell Lymphoma (PTCL), iveza izinselelo ezinkulu. Enye yezinkinga eziyinhloko ifana phakathi kwama-T-cell anobungozi nama-T-cell ajwayelekile, okwenza kube nzima ukuhlasela amaseli anomdlavuza kuphela ngaphandle kokulimaza ama-T-cell anempilo. Lokhu kuphumela esimeni esaziwa ngokuthi “i-fratricide,” lapho amaseli e-CAR-T ehlasela ama-T-cell anobungozi kanye nama-T-cell ajwayelekile, okunciphisa kakhulu ukusebenza kahle kokwelashwa. Ngaphezu kwalokho, ukungafani kwezifo ezibangelwa amagciwane e-T kwenza kube nzima ukuhlonza izisulu zamaseli e-CAR-T ajwayelekile, njengoba i-antigen eyodwa eqondiwe ingase ingavezwa ngokufanayo kuwo wonke amaseli omdlavuza.

12.11.2.webp

 

Ezivivinyweni zemitholampilo, amaseli e-CAR-T ahlose ama-antigen e-pan-T njenge-CD5 ne-CD7 abonise impumelelo ethile ekwelapheni umdlavuza we-T-cell. Lawa ma-target atholakala ebusweni be-T-cell monosages eziningi, kodwa futhi abonakala kumaseli e-T ajwayelekile, okuholela emiphumeleni emibi emibi njengokuncipha kwamaseli e-T, ukuntuleka kwamasosha omzimba, kanye nokwanda kokuthambekela ekuthelelekeni. Ukuze kuncishiswe lezi zinselele, abacwaningi bagxile kuma-antigen e-T-cell athile “avinjelwe”, njenge-CD4, i-CD30, i-CD37, kanye ne-CCR4. Lawa ma-antigen akhetha kakhulu ama-subset athile amaseli e-T, okungase kunciphise ingozi ye-fratricide futhi kulondoloze ukusebenza okuvamile komzimba. Kodwa-ke, ucwaningo ngala ma-antigen avinjelwe lusesezigabeni zokuqala, futhi ukukhetha isiguli ngokucophelela kubalulekile ukuze kunqunywe i-target efanele kakhulu yecala ngalinye.

 

Elinye isu elihlolwayo lihilela ukuthuthukiswa kwamaseli e-CAR-T a-allogeneic, atholakala kubanikeli abanempilo kunasezigulini uqobo. Amaseli e-CAR-T a-allogeneic angahlelwa ngokwezakhi zofuzo ukuvimbela ukungcoliswa kwesimila nokunciphisa ingozi yesifo se-graft-versus-host (GvHD), okuyinkinga evamile ezindaweni zokufakelwa. Kodwa-ke, lawa maseli abhekene nezinselele ezifana nokwenqatshwa kwamasosha omzimba, okunganciphisa ukusebenza kwawo kwesikhathi eside. Ukuze kuxazululwe lokhu, amasu okuhlela izakhi zofuzo njenge-CRISPR/Cas9 kanye nokuhlela okuyisisekelo ayahlolwa ukuze kuguqulwe amaseli e-CAR-T, okwenza asebenze kabanzi futhi aphephe kakhulu ezigulini. Ukuhlela okuyisisekelo, ikakhulukazi, kunikeza enye indlela ethembisayo yokuhlela izakhi zofuzo zendabuko, njengoba kugwema izingozi ezihambisana nokuqhekeka kwe-DNA yezintambo ezimbili, ukunciphisa ubuthi bezakhi zofuzo nokuthuthukisa iphrofayili yokuphepha yezindlela zokwelapha ze-CAR-T.

 

Naphezu kwalokhu kuthuthuka, kusenezinselele eziningana. Amaseli e-CAR-T avame ukungakwazi ukugcina ukuphikelela isikhathi eside emzimbeni, okungaholela ekubuyeleni kwesifo. Ngemva kokwelashwa ngamaseli e-CAR-T aqondiswe ku-CD7, isibonelo, amaseli e-T angenayo i-CD7 angavela futhi amelane nokubulawa kwamaseli e-CAR-T, okwenza kube nzima kakhulu ukwelashwa. Abacwaningi baphenya ngezindlela zokuthuthukisa isikhathi eside nokusebenza kahle kwamaseli e-CAR-T, okuhlanganisa ukuhlanganisa ukwelashwa kwe-CAR-T nezinye izindlela zokwelapha, njengokufakelwa kwamaseli e-stem, ukuqinisa nokugcina ukuxolelwa. Le ndlela, eyaziwa ngokuthi "ukwelashwa kokuvala," inganikeza ungqimba olwengeziwe lokuvikela ekubuyeleni kwesifo, ikakhulukazi ezigulini ezinomthwalo omkhulu wesimila.

 

Izinkinga ezilandela ukwelashwa kwe-CAR-T, okuhlanganisa i-cytokine release syndrome (CRS), i-immune effector cell-associated neurotoxicity syndrome (ICANS), kanye nezifo ezithinta amathuba, nazo ziyizindawo ezikhathazayo. Ukuncipha kwamaseli e-T, ikakhulukazi, kushiya iziguli zisengozini yokuvuselelwa kwezifo ezifihliwe njengegciwane le-Epstein-Barr (EBV) kanye ne-cytomegalovirus (CMV), kuyilapho ukucindezelwa komnkantsha kungaholela ekukhuleni kwe-cytopenia isikhathi eside. Ukuze kuncishiswe lezi zingozi, abacwaningi baphenya ngezindlela zokuthuthukisa ukuphepha nokusebenza kahle kwamaseli e-CAR-T, njengokwethula ukushintsha kokuphepha nokusebenzisa izindlela zokwelapha ezimfushane ukuze kuncishiswe imiphumela emibi.

 

Sekukonke, yize ukwelashwa kwe-CAR-T kuye kwenza intuthuko ebalulekile ekwelapheni umdlavuza wegazi we-T-cell, izinselele ezihlobene nokuqondisa ama-antigen, izinkinga zesistimu yomzimba, kanye nokuphikelela kwesikhathi eside zisekhona. Ucwaningo oluqhubekayo kanye nokusungula izinto ezintsha kubuchwepheshe be-CAR-T, okuhlanganisa ukuthuthukiswa kwezindlela zokwelapha ezihloselwe kabili, amasu okuhlela izakhi zofuzo, kanye nokukhethwa kweziguli okunembe kakhudlwana, kubalulekile ekuvuleni amandla okwelapha e-CAR-T ekwelapheni umdlavuza we-T-cell. Njengoba izivivinyo zemitholampilo ziqhubeka nokuhlola amasu amasha, ithemba liwukuthi ukwelashwa kwe-CAR-T kuzothuthuka ukuze kunikeze izinketho zokwelapha ezihlala isikhathi eside neziphephile ezigulini ezinalezi zinhlungu zomdlavuza eziyinselele.